CDKN1B and hepatocellular carcinoma: Thus, the cytoplasmic delocalization of PATZ1 tumor suppressor in the HCC cell lines might negate its nuclear transcriptional activation of CDKN1B, thereby resulting in reduced expression of CDKN1B.